First-line FOLFOX plus panitumumab followed by 5-FU/LV plus panitumumab or single-agent panitumumab as maintenance therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC): The VALENTINO study
Keyword(s):
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS3634-TPS3634
Keyword(s):
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. 3505-3505
◽
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 51
(11)
◽
pp. 1371-1380
◽
Keyword(s):